NRS Chiesi Young Investigator Award
The NRS wishes to provide a yearly prize for a young investigator in order to stimulate research in the area of respiratory diseases. The prize, which has been designated as the "NRS Young Investigator Award" has been made possible by Chiesi Pharmaceuticals B.V. In order to award this prize to the most deserving candidate, the NRS organizes a yearly competition. Contestants for this award need to fulfill a number of requirements. These include, amongst others, that the researcher in question has submitted an abstract to the Dutch Lung Congress, is younger than 35 years at the time of the Dutch Lung Congress, is a member of the NRS and is willing to give a lecture during this meeting. The NRS Young Investigator Board judges the submissions and ascertains the best abstracts.
Chiesi Young Investigator Award- There were 5 highly Commended Recipients (€400 prize each): Glenn van Hulst, Liege "Single-cell proteomics and transcriptomics resolve eosinopoiesis and the role of IL-5 in eosinophil lineage transit amplification." Julia Scott, Utrecht "Cohesin-STAG2 controls cell fate decisions via pioneer factor FOXA2 in lung cancer" Li Jia, Leiden "Development of structural and immune cell in the fetal lung" Elise Slob, Amsterdam "ADRB2 genotype-guided treatment for childhood asthma: an individual patient data meta-analysis of the PACT and PUFFIN trial" Daphne Peerlings, Maastricht "Longitudinal follow-up of spirometry parameters in patients with COPD during pulmonary rehabilitation"
Chiesi Young Investigator Award: Sacha Spelier from Wilhelmina University Medical Center, Utrecht, received €3,000 for her project on "Organoid-guided synergistic treatment of minimal function CFTR mutations with CFTR modulators, roflumilast, and simvastatin: a personalized approach." The expert panel praised her clear explanation of the journey from bench to bedside and her impressive out-of-the-box approach.
Awarding the Chiesi Young Investigators Award-Highly Commended 30 June 2023 Dutch Lung Congress From left to right Prof. dr. Huib Kerstjens (President NRS), Lisette Krabbendam, PhD (Chiesi Group) Laura Houweling (The effect of the urban exposome on COVID-19 health outcomes: a systematic review and meta-analysis), Stefan Neys (The fibrosis and angiogenesis inhibitor nintedanib represses antigen receptor signaling and downstream effector functions in B and T cells), Roy Woldhuis (Cellular senescence impacts regulators of ECM and contributes to ECM dysregulation in COPD patients), Lianne Trap (Decoding the Genetic Predisposition to Asthma Using Epigenomics)
Congratulations Pauline Kuks on winning the Chiesi Young Investigator Award on the 30th June during the DLC; with her presentation titled: Cluster analysis to identify distinct clinical asthma phenotypes within ATLANTIS. Thank you Chiesi for being a loyal sponsor to the NRS and for supporting this award.
